1. Home
  2. SLP vs BOE Comparison

SLP vs BOE Comparison

Compare SLP & BOE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLP
  • BOE
  • Stock Information
  • Founded
  • SLP 1996
  • BOE 2005
  • Country
  • SLP United States
  • BOE United States
  • Employees
  • SLP N/A
  • BOE N/A
  • Industry
  • SLP EDP Services
  • BOE Trusts Except Educational Religious and Charitable
  • Sector
  • SLP Technology
  • BOE Finance
  • Exchange
  • SLP Nasdaq
  • BOE Nasdaq
  • Market Cap
  • SLP 675.9M
  • BOE 634.0M
  • IPO Year
  • SLP 1997
  • BOE N/A
  • Fundamental
  • Price
  • SLP $18.32
  • BOE $11.42
  • Analyst Decision
  • SLP Buy
  • BOE
  • Analyst Count
  • SLP 7
  • BOE 0
  • Target Price
  • SLP $40.40
  • BOE N/A
  • AVG Volume (30 Days)
  • SLP 571.2K
  • BOE 166.1K
  • Earning Date
  • SLP 07-14-2025
  • BOE 01-01-0001
  • Dividend Yield
  • SLP 0.32%
  • BOE 7.30%
  • EPS Growth
  • SLP N/A
  • BOE N/A
  • EPS
  • SLP 0.36
  • BOE N/A
  • Revenue
  • SLP $78,564,000.00
  • BOE N/A
  • Revenue This Year
  • SLP $27.66
  • BOE N/A
  • Revenue Next Year
  • SLP $6.75
  • BOE N/A
  • P/E Ratio
  • SLP $51.73
  • BOE N/A
  • Revenue Growth
  • SLP 21.49
  • BOE N/A
  • 52 Week Low
  • SLP $16.72
  • BOE $8.80
  • 52 Week High
  • SLP $49.05
  • BOE $10.48
  • Technical
  • Relative Strength Index (RSI)
  • SLP 29.54
  • BOE 64.66
  • Support Level
  • SLP $16.78
  • BOE $11.12
  • Resistance Level
  • SLP $17.70
  • BOE $11.29
  • Average True Range (ATR)
  • SLP 1.15
  • BOE 0.08
  • MACD
  • SLP -0.00
  • BOE 0.01
  • Stochastic Oscillator
  • SLP 14.61
  • BOE 98.72

About SLP Simulations Plus Inc.

Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.

About BOE Blackrock Enhanced Global Dividend Trust of Beneficial Interest

Blackrock Enhanced Global Dividend Trust has an investment objective to provide current income and current gains, with a secondary investment objective of long-term capital appreciation. Further, it focuses on investing in a portfolio of equity securities and utilizing an option writing to seek total return performance and enhance distributions.

Share on Social Networks: